CIK 0001763950 · Non-accelerated filer<br>Smaller reporting company
Lantern Pharma Inc.
Sign in to watch- Ticker
- LTRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 463973463
- Phone
- 972-277-1136
- Business address
- 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
- Former names
- Lantern Pharma
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-15 | Margrave David R. CFO and Secretary | Grant or award · Stock Option | +78,300 | 78,300 | ||
| 2020-06-15 | KEYSER D JEFFREY Director | Conversion | +31,927 | 41,927 | ||
| 2020-06-15 | KEYSER D JEFFREY Director | Conversion · Series A Preferred Stock | −18,349 | 0 | ||
| 2020-06-15 | KEYSER D JEFFREY Director | Grant or award · Stock Option | +9,135 | 9,135 | ||
| 2020-06-11 | KEYSER D JEFFREY Director | Purchase | +10,000 | $15.00 | $150K | 10,000 |
Page 13 of 13 · 245 trades